ABBV vs ABT Stock Comparison
Scores Breakdown
| Metric | ABBV | ABT |
|---|---|---|
| 📈 Growth | 15/30 | 22/30 |
| 💰 Profitability | 16/20 | 17/20 |
| 🏦 Financial Health | 12/20 | 15/20 |
| 💵 Valuation | 12/20 | 12/20 |
| ⚠️ Risk (lower is better) | 6/10 | 4/10 |
| Overall Score | 59/100 | 72/100 |
Side-by-Side Summaries
| ABBV Analysis | ABT Analysis |
|---|---|
📈 Growth & Financial Trajectory8 quarters show a largely rising topline: 2024Q1 to 2026Q1 Revenues rise from about $12.31B to $15.00B (+≈22%). Net income attributable to parent falls from ~$1.29B to ~$0.70B, though peaks around ~$1.86B in 2025Q2–Q3, with 2025Q4 at ~$1.82B. The trend is mixed: topline strength persists, but bottom-line profitability weakens into 2026Q1. 💰 Margins & Cash FlowGross margins remain high, broadly ~70–79%, reflecting a durable product mix. Operating leverage remains healthy as volumes expand. Net cash flow from operating activities stays robust, typically around $5.1B–$5.3B per quarter; investing activity is negative (capex/activity), and financing flows cause periodic swings. 🛡️ Balance Sheet & LiquidityTotal assets hover near the mid-to-upper hundreds of billions with liabilities that verge on or exceed assets in some periods, and equity attributable to the parent is often negative (reflecting buybacks). The firm generates solid operating cash flow that supports liquidity despite leverage. Long-term debt runs in the mid-$60B range in recent periods, with current liabilities ~$39–$44B. ⚠️ Key Drivers & Risks
|
📈 Growth & Financial TrajectoryOver the 8-quarter window, Revenue gravitated around $9.96B to $11.16B, ending at $11.16B in 2026 Q1, a start-to-end rise of about $1.2B (~12%). Net income remained positive through most quarters, with modest-to-strong fluctuations; several quarters show mid-single-digit billions in income, with notable variability from one-off items (e.g., tax effects). 💰 Margins & Cash FlowGross Margin was solid, around 56% on average (Gross Profit ~6.3B vs Revenues ~11.2B in 2026 Q1). Operating margin ranged roughly from 12% to 18%, peaking in 2025 Q2. Net cash flow from operating activities was consistently positive (e.g., 2026 Q1: $1.315B; prior quarters in the 1.4–2.9B range), while investing activities were typically cash outflows and financing modest. 🛡️ Balance Sheet & LiquidityTotal assets approximate $72B–$110B over the period with equity in the low-to-mid $50B range. The company shows a healthy current ratio ( ⚠️ Key Drivers & Risks
|